Status:
UNKNOWN
Image Guided RFA/MWA/CRYO of RCC Biomarker Profile Study
Lead Sponsor:
University of Leeds
Collaborating Sponsors:
The Leeds Teaching Hospitals NHS Trust
Conditions:
Renal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Often kidney cancer is diagnosed when the tumour is small and hasn't spread. Rather than major surgery to remove the whole kidney, image-guided ablation involving heat (microwave or radiofrequency) or...
Detailed Description
Image-guided ablation therapies are increasingly being used in renal and other cancers as an alternative to major surgery, particularly in the context of small localised masses or when patients have s...
Eligibility Criteria
Inclusion
- Patients underwent image guided ablation for renal cell carcinoma (RCC) with heat-based energy (RFA/MWA) or ice-based energy (CRYO)
- No other prior treatment to RCC in either kidneys
Exclusion
- 1\. Patients with RCC that is not suitable for image guided ablation
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04392076
Start Date
June 1 2019
End Date
December 31 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds Institute of Medical Research
Leeds, West Yorkshire, United Kingdom, LS9 7TF